Skip to main content

Table 1 Detail of demographic data and baseline signs, symptoms, and laboratory findings of all studied participants

From: Predictors of the chest CT score in COVID-19 patients: a cross-sectional study

Variables

All patients N = 478

Demographics

Age (years)

53.92(15.4)

 < 39

90 (18.8%)

 39–49

102 (21.3%)

 50–59

104 (21.7%)

 60–69

98 (20.5%)

 ≥ 70

84 (17.5%)

Gender (male)

267 (55.8%)

Symptoms on the first visit

Myalgia

289 (60.4%)

Generalized weakness

217 (45.3%)

Fever

284 (59.4%)

Chills

237 (49.5%)

Headache

134 (28%)

Chest pain

126 (26.3%)

Dyspnea

277 (57.9%)

Sore throat

80 (16.7%)

Cough

334 (69.8%)

Sputum

15 (3.1%)

Loss of appetite

194 (40.5%)

Loss of taste

48 (10%)

Anosmia

60 (12.5%)

Vital signs on first visit

Temperature (°C)

 

 ≤ 37.2

212 (44.3%)

 ≥ 37.3

266 (55.7%)

O2 saturation %

 

 ≥ 93

276 (57.7%)

 < 93

202 (42.3%)

Respiratory rate (breaths/minute)

 < 25

389 (81.3%)

 ≥ 25

89 (18.7%)

Initial laboratory findings

White blood cell (WBC) (cell/ mm3)

 

 < 4000

51 (10.6%)

 4000–9999

364 (76.3%)

 ≥ 10,000

63 (13.1%)

Lymphocyte count (cell/ mm3)

 ≤ 1000

103 (21.5%)

 > 1000

375 (78.5%)

Platelet (cell/mm3)

 < 150,000

82 (17.1%)

 ≥ 150,000

396 (82.9%)

C-reactive protein (CRP) (mg/L)

 ≤ 90

17 (3.5%)

 ≥ 91

461 (96.5%)

Erythrocyte sedimentation rate (ESR) (mm/h)

 ≤ 60

13 (2.7%)

 ≥ 61

465 (97.3%)

Lactate dehydrogenase (LDH) (units/L)

 < 480

65 (13.5%)

 ≥ 480

413 (86.5%)

Underlying disease

 DM

132 (27.6%)

 HTN

136 (28.4%)

  1. All variables are reported as N (%)
  2. HTN: hypertension, DM: diabetes mellitus